Ben Emons says the FDA approval of Pfizer's Covid-19 makes for a confident outlook and has provided a lift to the markets. FDA approval may also help breach the political divide over the vaccine uptake and reluctance. Ben also sees the industrial and retail sectors benefiting from the the most recent vaccine news news. In terms of QE tapering, Ben does not expect a decision during the upcoming Jackson Hole symposium, but rather more information in the coming months closer to the end of the calendar year.